Patency of the preterm fetal ductus arteriosus is regulated by endothelial nitric oxide synthase and is independent of vasa vasorum in the mouse
Open Access
- 1 September 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 287 (3) , R652-R660
- https://doi.org/10.1152/ajpregu.00049.2004
Abstract
Patency of the fetal ductus arteriosus (DA) is maintained in an environment of low relative oxygen tension and a preponderance of vasodilating forces. In addition to prostaglandins, nitric oxide (NO), a potent vasodilator in the pulmonary and systemic vasculatures, has been implicated in regulation of the fetal DA. To further define the contribution of NO to DA patency, the expression and function of NO synthase (NOS) isoforms were examined in the mouse DA on days 17–19 of pregnancy and after birth. Our results show that endothelial NOS (eNOS) is the predominant isoform expressed in the mouse DA and is localized in the DA endothelium by in situ hybridization. Despite rapid constriction of the DA after birth, eNOS expression levels were unchanged throughout the fetal and postnatal period. Pharmacological inhibition of prostaglandin vs. NO synthesis in vivo showed that the preterm fetal DA on day 16 is more sensitive to NOS inhibition than the mature fetal DA on day 19, whereas prostaglandin inhibition results in marked DA constriction on day 19 but minimal effects on the day 16 DA. Combined prostaglandin and NO inhibition caused additional DA constriction on day 16. The contribution of vasa vasorum to DA regulation was also examined. Immunoreactive platelet endothelial cell adhesion molecule and lacZ tagged FLK1 localized to DA endothelial cells but revealed the absence of vasa vasorum within the DA wall. Similarly, there was no evidence of vasa vasorum by vascular casting. These studies indicate that eNOS is the primary source of NO in the mouse DA and that vasomotor tone of the preterm fetal mouse DA is regulated by eNOS-derived NO and is potentiated by prostaglandins. In contrast to other species, mechanisms for DA patency and closure appear to be independent of any contribution of the vasa vasorum.Keywords
This publication has 59 references indexed in Scilit:
- Voltage-gated potassium channels in human ductus arteriosusPublished by Elsevier ,2000
- Role of Nitric Oxide in Regulating the Ductus Arteriosus Caliber in Fetal Rats.The Journal of Veterinary Medical Science, 2000
- Indomethacin Tocolysis Increases Postnatal Patent Ductus Arteriosus SeverityPediatrics, 1998
- Patent Ductus Arteriosus and Neonatal Death in Prostaglandin Receptor EP4-Deficient MiceBiochemical and Biophysical Research Communications, 1998
- Role of inducible nitric oxide synthase in regulation of pulmonary vascular tone in the late gestation ovine fetus.Journal of Clinical Investigation, 1998
- Nitro containing L-arginine analogs interfere with assays for nitrate and nitriteLife Sciences, 1995
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.Journal of Clinical Investigation, 1994
- Ultrastructural and Histological Studies on Closure of the Mouse Ductus arteriosusCells Tissues Organs, 1990
- Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofenCanadian Journal of Physiology and Pharmacology, 1979